Cargando…

SARS-CoV-2 seroprevalence in Spain

Detalles Bibliográficos
Autores principales:	Hoffmann, Christian, Wolf, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837169/ https://www.ncbi.nlm.nih.gov/pubmed/33160562 http://dx.doi.org/10.1016/S0140-6736(20)32272-8

Ejemplares similares

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Seroprevalence and presentation of SARS-CoV-2 in pregnancy
por: Crovetto, Francesca, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees
por: Hanage, William P, et al.
Publicado: (2020)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

MPXV and SARS-CoV-2 in the air of nightclubs in Spain
por: Sanchiz, África, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
por: Arora, Rahul K, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence Studies in Pets, Spain
por: Barroso-Arévalo, Sandra, et al.
Publicado: (2023)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
por: Malani, Anup, et al.
Publicado: (2021)

Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
por: García-García, Elisa, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Among Pediatric Healthcare Workers in Spain
por: Dacosta-Urbieta, Ana, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020
por: Wang, Shichun, et al.
Publicado: (2022)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022
por: García-Sempere, Aníbal, et al.
Publicado: (2023)

Neuropathology associated with SARS-CoV-2 infection
por: Glatzel, Markus, et al.
Publicado: (2021)

Beau‐Lines of the fingernails in association with pediatric SARS‐CoV‐2 infections
por: Wolf, Gerhard K., et al.
Publicado: (2021)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Neuropathology associated with SARS-CoV-2 infection
por: Egervari, Kristof, et al.
Publicado: (2021)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2
por: Pfaff, Florian, et al.
Publicado: (2022)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
por: Arora, Prerna, et al.
Publicado: (2023)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

Unclear conclusions on SARS-CoV-2 elimination versus mitigation
por: Gold, Christian
Publicado: (2021)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

A retrospective study of SARS-CoV-2 seroprevalence in dogs and cats in the Community of Madrid, Spain
por: Sánchez-Morales, Lidia, et al.
Publicado: (2023)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t698nte6si739sqbhsf5r64o79